Polaris Inc. 8-K

What Happened
Polaris Inc. announced that at its April 30, 2026 Annual Meeting shareholders approved an amendment and restatement of the Polaris Inc. 2024 Omnibus Incentive Plan, increasing the total share pool for awards. Stockholders also elected three Class II directors, approved a non‑binding advisory vote on executive compensation, and ratified Ernst & Young LLP as the company’s independent auditor for fiscal 2026. The company filed the amended plan as Exhibit 10.1 to the 8‑K.

Key Details

• Record date for the meeting: March 9, 2026 (56,615,893 shares outstanding); shares voted at the meeting: 51,080,000.
• Omnibus Plan change: aggregate share authorization increased by 4,580,000 shares — from 4,325,000 to 8,905,000 shares.
• Director elections (three-year terms ending 2029): George W. Bilicic (For: 39,035,129), Gary E. Hendrickson (For: 39,057,930), Gwenne A. Henricks (For: 41,261,458). Continuing directors include Darryl R. Jackson, Bernd F. Kessler, Lawrence D. Kingsley, Gwynne E. Shotwell, Michael T. Speetzen, and John P. Wiehoff.
• Say‑on‑pay (non‑binding): Approved — For: 39,166,733; Against: 4,275,833; Abstain: 317,825.
• Omnibus Plan approval vote: For: 37,055,736; Against: 6,446,556; Abstain: 258,099.
• Auditor ratification: Ernst & Young LLP ratified — For: 49,407,749; Against: 1,320,850; Abstain: 351,401.
• 8‑K signed May 1, 2026 by Matthew S. Winings, SVP—General Counsel & Corporate Secretary.

Why It Matters
Approving the amended Omnibus Incentive Plan gives Polaris a larger pool of shares it can grant as stock-based compensation, which management can use for retention and incentive awards; that may lead to additional dilution for existing shareholders over time. The director elections and the favorable advisory vote on executive pay indicate shareholder support for current leadership and compensation practices. Ratifying Ernst & Young confirms the firm that will audit Polaris’s fiscal 2026 financials. Investors should note the increase in authorized award shares and monitor future equity grant activity for potential dilution.